212-681-1575

In November, MesotheliomaHelp reported on the encouraging results with the experimental cancer drug known as CRS-207 in its ongoing Phase 1b trial. Now Aduro Biotech, the maker of CRS-207, is joining forces with Merck, the pharmaceutical company that markets the ...
Continue Reading

Want Specific topic updates?

Last week MesotheliomaHelp reported on the drive towards using DNA sequencing on cancer patients in an effort to determine the appropriate treatment based on the patients’ bi ...

Read Full Story

Want Specific topic updates?

Medical Research doing some experiments

Targeted care optimizes the potential for success of mesothelioma treatment and provides the patient with the assurance that his cancer is being treated according to his unique cha ...

Read Full Story

Want Specific topic updates?

Mesothelioma, an asbestos-caused cancer, comes with debilitating pain. Patients and their doctors often  try a variety of options to relieve the pain, but still, it persists. Many ...

Read Full Story

Want Specific topic updates?

In pursuit of its mission to protect the public health by ensuring the safety and efficacy of drugs, the U.S. Food and  Drug Administration sent out warning letters to 14 companie ...

Read Full Story

Want Specific topic updates?

1 2 3 39